Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Multi-center, Randomized, Double blind, Controlled Parallel-group Comparative Phase 3
Clinical trial to assess the efficacy and safety of Pelubiprofen Compared to Loxoprofen in
patients with Acute upper respiratory infection.